试管婴儿补充剂:有效性,效率,安全性和额外成本 - SIFES-MR的立场声明
Danilo Cimadomo1, Mauro Cozzolino2, Andrea Busnelli3
1Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Rome, Italy.
概括
试管婴儿补充剂需要进行批判性评估. 虽然有些,如PGT-A,在特定情况下显示出希望,但其他则缺乏证据或构成风险. 基于证据的实践和明确的患者沟通对于辅助生殖技术至关重要.
科学领域:
- 生殖医学 生殖医学
- 在体外受精 (IVF)
背景情况:
- 试管婴儿补充剂是标准程序的附加品.
- 它们的有效性,安全性和成本效益差异很大.
- 基于证据的选择对于患者护理至关重要.
研究的目的:
- 批判性地评估试管婴儿的补充.
- 提供基于当前证据和专家共识的建议.
- 为了指导临床实践和患者咨询.
主要方法:
- 多学科专家小组在两年内达成共识.
- 修订国际指导方针 (ESHRE,HFEA,ISAR,ASRM) 的内容.
- 文献审查和德尔菲共识工作流程.
主要成果:
- 预植入前遗传测试 (PGT-A) 显示出在特定人群中具有潜力.
- 其他附加程序缺乏足够的证据或引发安全问题.
- 不建议进行子宫内膜受体测试和mtDNA负载测量.
结论:
- 在辅助生殖技术 (ART) 中强调基于证据的实践.
- 强调需要明确的患者沟通和咨询.
- 倡导进一步研究和对IVF补充剂的监管监督.
相关概念视频
In Vitro Fertilization
395
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
395
Infertility in Males
333
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
333
Infertility in Females
404
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
404
Standards of Care II
727
Nurses bear specific legal responsibilities under several federal statutes, including:
727


